The data obtained in the fluorometric reaction in the cell-free system show that EGCG works as an HDAC inhibitor, which was confirmed in cellular experimental models: non-tumor (Figure 5) as well as tumor cell lines, e.g., colon carcinoma cell line HT29 [20]. The gene discussed is HDAC9; the disease is colon carcinoma.